AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Activation of stress-activated protein kinase in osteoarthritic cartilage:evidence for nitric oxide dependence
Authors: Clancy, R Rediske, J Koehne, C Stoyanovsky, D Amin, A Attur, M Iyama, K Abramson, SB
Citation: R. Clancy et al., Activation of stress-activated protein kinase in osteoarthritic cartilage:evidence for nitric oxide dependence, OSTEO CART, 9(4), 2001, pp. 294-299
Controversies in COX-2 inhibitor therapy - Introduction
Authors: Abramson, SB
Citation: Sb. Abramson, Controversies in COX-2 inhibitor therapy - Introduction, CLIN EXP RH, 19(6), 2001, pp. S1-S2
Controversies in COX-2 inhibitor therapy: Closing remarks
Authors: Abramson, SB Furst, DE Hochberg, MC Patrono, C
Citation: Sb. Abramson et al., Controversies in COX-2 inhibitor therapy: Closing remarks, CLIN EXP RH, 19(6), 2001, pp. S77-S80
A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee
Authors: Pincus, T Koch, GG Sokka, T Lefkowith, J Wolfe, F Jordan, JM Luta, G Callahan, LF Wang, X Schwartz, T Abramson, SB Caldwell, JR Harrell, RA Kremer, JM Lautzenheiser, RL Markenson, JA Schnitzer, TJ Weaver, A Cummins, P Wilson, A Morant, S Fort, J
Citation: T. Pincus et al., A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee, ARTH RHEUM, 44(7), 2001, pp. 1587-1598
Osteoarthritis, an inflammatory disease - Potential implication for the selection of new therapeutic targets
Authors: Pelletier, JP Martel-Pelletier, J Abramson, SB
Citation: Jp. Pelletier et al., Osteoarthritis, an inflammatory disease - Potential implication for the selection of new therapeutic targets, ARTH RHEUM, 44(6), 2001, pp. 1237-1247
Circulating activated endothelial cells in systemic lupus erythematosus - Further evidence for diffuse vasculopathy
Authors: Clancy, R Marder, G Martin, V Belmont, HM Abramson, SB Buyon, J
Citation: R. Clancy et al., Circulating activated endothelial cells in systemic lupus erythematosus - Further evidence for diffuse vasculopathy, ARTH RHEUM, 44(5), 2001, pp. 1203-1208
Osteopontin - An intrinsic inhibitor of inflammation in cartilage
Authors: Attur, MG Dave, MN Stuchin, S Kowalski, AJ Steiner, G Abramson, SB Denhardt, DT Amin, AR
Citation: Mg. Attur et al., Osteopontin - An intrinsic inhibitor of inflammation in cartilage, ARTH RHEUM, 44(3), 2001, pp. 578-584
Differential anti-inflammatory effects of immunosuppressive drugs: Cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE(2) production
Authors: Attur, MG Patel, R Thakker, G Vyas, P Levartovsky, D Patel, P Naqvi, S Raza, R Patel, K Abramson, D Bruno, G Abramson, SB Amin, AR
Citation: Mg. Attur et al., Differential anti-inflammatory effects of immunosuppressive drugs: Cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE(2) production, INFLAMM RES, 49(1), 2000, pp. 20-26
Model protocol to study pharmacogenomics in inflammatory diseases: Human rheumatoid arthritis
Authors: Attur, M Bingham, CO Dave, M Abramson, SB Amin, AR
Citation: M. Attur et al., Model protocol to study pharmacogenomics in inflammatory diseases: Human rheumatoid arthritis, DRUG DEV R, 49(1), 2000, pp. 29-33
Nitric oxide synthase/COX cross-talk: Nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production
Authors: Clancy, R Varenika, B Huang, WQ Ballou, L Attur, M Amin, AR Abramson, SB
Citation: R. Clancy et al., Nitric oxide synthase/COX cross-talk: Nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production, J IMMUNOL, 165(3), 2000, pp. 1582-1587
Functional genomic analysis in arthritis-affected cartilage: Yin-yang regulation of inflammatory mediators by alpha(5)beta(1) and alpha(v)beta(3) integrins
Authors: Attur, MG Dave, MN Clancy, RR Patel, IR Abramson, SB Amin, AR
Citation: Mg. Attur et al., Functional genomic analysis in arthritis-affected cartilage: Yin-yang regulation of inflammatory mediators by alpha(5)beta(1) and alpha(v)beta(3) integrins, J IMMUNOL, 164(5), 2000, pp. 2684-2691
Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type IIIL-1 decoy receptor - Potential for pharmacological intervention
Authors: Attur, MG Dave, M Cipolletta, C Kang, P Goldring, MB Patel, IR Abramson, SB Amin, AR
Citation: Mg. Attur et al., Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type IIIL-1 decoy receptor - Potential for pharmacological intervention, J BIOL CHEM, 275(51), 2000, pp. 40307-40315
Acetylcholine prevents intercellular adhesion molecule 1 (CD54)-induced focal adhesion complex assembly in endothelial cells via a nitric oxide-cGMP-dependent pathway
Authors: Clancy, RM Abramson, SB
Citation: Rm. Clancy et Sb. Abramson, Acetylcholine prevents intercellular adhesion molecule 1 (CD54)-induced focal adhesion complex assembly in endothelial cells via a nitric oxide-cGMP-dependent pathway, ARTH RHEUM, 43(10), 2000, pp. 2260-2264
Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
Authors: Crofford, LJ Lipsky, PE Brooks, P Abramson, SB Simon, LS Van de Putte, LBA
Citation: Lj. Crofford et al., Basic biology and clinical application of specific cyclooxygenase-2 inhibitors, ARTH RHEUM, 43(1), 2000, pp. 4-13
Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease
Authors: Lipsky, PE Brooks, P Crofford, LJ DuBois, R Graham, D Simon, LS van de Putte, LBA Abramson, SB
Citation: Pe. Lipsky et al., Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease, ARCH IN MED, 160(7), 2000, pp. 913-920
The pleiotropic functions of aspirin: mechanisms of action
Authors: Amin, AR Attur, MG Pillinger, M Abramson, SB
Citation: Ar. Amin et al., The pleiotropic functions of aspirin: mechanisms of action, CELL MOL L, 56(3-4), 1999, pp. 305-312
Regulation of nitric oxide and inflammatory mediators in human osteoarthritis-affected cartilage: Implication for pharmacological intervention
Authors: Amin, AR Attur, MG Abramson, SB
Citation: Ar. Amin et al., Regulation of nitric oxide and inflammatory mediators in human osteoarthritis-affected cartilage: Implication for pharmacological intervention, EN CEL RE S, 5, 1999, pp. 397-412
Patients, physicians, and clinical trials: The other side of the coins
Authors: Flexner, C Abramson, SB Snyderman, R Dieterich, DT Korn, D Temple, R Sherwood, L Goldblatt, D
Citation: C. Flexner et al., Patients, physicians, and clinical trials: The other side of the coins, J INVES MED, 47(8), 1999, pp. 343-357
Second International Workshop of the Osteoarthritis Research Society International (OARSI) - Florence, Italy, - 15-17 October 1998 - Foreword
Authors: Pelletier, JP Abramson, SB
Citation: Jp. Pelletier et Sb. Abramson, Second International Workshop of the Osteoarthritis Research Society International (OARSI) - Florence, Italy, - 15-17 October 1998 - Foreword, OSTEO CART, 7(4), 1999, pp. 359-360
The role of COX-2 produced by cartilage in arthritis
Authors: Abramson, SB
Citation: Sb. Abramson, The role of COX-2 produced by cartilage in arthritis, OSTEO CART, 7(4), 1999, pp. 380-381
Regulation of nitric oxide and prostaglandin E-2 production by CSAIDS (TM)(SB203580) in murine macrophages and bovine chondrocytes stimulated with LPS
Authors: Patel, R Attur, MG Dave, MN Kumar, S Lee, JC Abramson, SB Amin, AR
Citation: R. Patel et al., Regulation of nitric oxide and prostaglandin E-2 production by CSAIDS (TM)(SB203580) in murine macrophages and bovine chondrocytes stimulated with LPS, INFLAMM RES, 48(6), 1999, pp. 337-343
Selective cyclooxygenase-2 inhibitors
Authors: Golden, BD Abramson, SB
Citation: Bd. Golden et Sb. Abramson, Selective cyclooxygenase-2 inhibitors, RHEUM DIS C, 25(2), 1999, pp. 359
A novel mechanism of action of chemically modified tetracyclines: Inhibition of COX-2-mediated prostaglandin E-2 production
Authors: Patel, RN Attur, MG Dave, MN Patel, IV Stuchin, SA Abramson, SB Amin, AR
Citation: Rn. Patel et al., A novel mechanism of action of chemically modified tetracyclines: Inhibition of COX-2-mediated prostaglandin E-2 production, J IMMUNOL, 163(6), 1999, pp. 3459-3467
Regulation of cytosolic COX-2 and prostaglandin E-2 production by nitric oxide in activated murine macrophages
Authors: Patel, R Attur, MG Dave, M Abramson, SB Amin, AR
Citation: R. Patel et al., Regulation of cytosolic COX-2 and prostaglandin E-2 production by nitric oxide in activated murine macrophages, J IMMUNOL, 162(7), 1999, pp. 4191-4197
Nitric oxide in systemic lupus erythematosus - Implications for immunity and inflammation
Authors: Belmont, HM Amin, AR Abramson, SB
Citation: Hm. Belmont et al., Nitric oxide in systemic lupus erythematosus - Implications for immunity and inflammation, CONT IMMUN, 7, 1999, pp. 21-42
Risultati: 1-25 | 26-28